Tech Company Financing Transactions
Avedro Funding Round
Abingworth, Third Point and private investors participated in a $43 million Series D venture round for Avedro. The financing round was announced on 3/6/2013.
Transaction Overview
Company Name
Announced On
3/6/2013
Transaction Type
Venture Equity
Amount
$43,000,000
Round
Series D
Investors
Abingworth (Lead Investor) (David Mayer)
Third Point (Jason Hong)
Proceeds Purpose
Proceeds from this financing will allow us to execute on both our global commercialization strategy and our US FDA approval strategy.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
201 Jones Rd.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Avedro (Nasdaq: AVDR) is a pharmaceutical and medical device company advancing the science and technology of corneal cross-linking and refractive correction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Reza Zadno
Chief Financial Officer
Thomas Griffin
Chief Marketing Officer
Rajesh Rajpal
Vice President
Stephen Zolla
VP - Engineering
Desmond Adler
VP - Marketing
Dave Iannetta
VP - Regulatory Affairs
Grace Lytle
VP - Regulatory Affairs
Pamela Nelson
Browse more venture capital transactions:
Prev: 3/6/2013: Pneuron venture capital transaction
Next: 3/6/2013: Appcore venture capital transaction
Share this article
Where The Data Comes From
We record all VC transactions involving tech companies. All VC database entries reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs